Publications by authors named "Maria Lomas"

Claim this Profile
P
Proliferation determined by ki67 marker and pCR in locally advanced breast cancer patients treated with neo-adjuvant chemotherapy.
Alfonso Sánchez-Muñoz, Yessica Plata-Fernández, Ana Jaén, María Lomas, Margarita Fernández

Breast J· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study on workload estimate in breast cancer, lung cancer and colorectal cancer in a Medical Oncology Service at Valme hospital.
Javier Salvador, Cristina Grávalos, Joan Albanell, Agustin Barnadas, Pablo Borrega, María Lomas

Clin Transl Oncol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functions and workload of medical oncologists in Spain.
Cristina Grávalos, Javier Salvador, Joan Albanell, Agustín Barnadas, Pablo Borrega, María Lomas

Clin Transl Oncol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classical markers like ER and ki-67, but also survivin and pERK, could be involved in the pathological response to gemcitabine, adriamycin and paclitaxel (GAT) in locally advanced breast cancer patients: results from the GEICAM/2002-01 phase II study.
Pedro Sánchez-Rovira, Antonio Antón, Agustí Barnadas, Amalia Velasco, María Lomas

Clin Transl Oncol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biweekly vinorelbine and tegafur/uracil in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: GEICAM 2000-02 phase II study.
Antonio Antón, Agustí Barnadas, Jesús Florián, Nuria Ribelles, María Lomas

Clin Transl Oncol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicentre phase II study to evaluate sequential docetaxel followed by capecitabine treatment in anthracycline-pretreated HER-2-negative patients with metastatic breast cancer.
Juan Bayo, María Lomas, Javier Salvador, Alberto Moreno, Manuel Ruiz

Clin Transl Oncol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective randomized phase III trial of etoposide/cisplatin versus high-dose epirubicin/cisplatin in small-cell lung cancer.
Angel Artal-Cortés, Jose Gomez-Codina, Jose Luis Gonzalez-Larriba, Isidoro Barneto, Alfredo Carrato, Maria Lomas

Clin Lung Cancer· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis